Abstract
Purpose
Anterior cutaneous nerve entrapment (ACNES) is characterized by neuropathic pain in a predictable, circumscript abdominal area. The diagnostic delay is long, with half of ACNES-affected individuals reporting nausea, bloating, or loss of appetite mimicking visceral disease. The aim of this study was to describe these phenomena and to determine whether treatment could successfully reverse the visceral symptoms.
Methods
This prospective observational study was conducted between July 2017 and December 2020 at SolviMáx, Center of Excellence for Chronic Abdominal Wall and Groin Pain, Máxima Medical Center, Eindhoven. Adult patients who fulfilled published criteria for ACNES and reported at least one visceral symptom at intake were eligible for the study. A self-developed Visceral Complaints ACNES Score (VICAS) questionnaire that scores several visceral symptoms (minimum 1 point, maximum 9 points) was completed before and after therapy. The success of treatment was defined as at least 50% reduction in pain.
Results
Data from 100 selected patients (86 females) aged 39 ± 5 years were available for analysis. Frequently reported symptoms were abdominal bloating (78%), nausea (66%) and altered defecation (50%). Successful treatment significantly reduced the number of visceral symptoms, with a VICAS before of 3 (range 1–8) and after of 1 (range 0–6) (p < 0.001). A low baseline VICAS was associated with successful treatment outcome (OR 0.738, 95% CI 0.546–0.999).
Conclusion
Patients with ACNES may report a variety of visceral symptoms. Successful treatment substantially reduces these visceral symptoms in selected patients.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
A potential source of chronic abdominal pain that is often neglected is the abdominal wall itself [1]. A typical example of a chronic abdominal wall pain condition is anterior cutaneous nerve entrapment syndrome (ACNES) [2, 3]. ACNES is thought to be due to compromised intercostal nerve endings that originate from the 7th to 12th thoracic vertebrae [4, 5]. These nerves penetrate the rectus abdominis muscle and innervate the overlying skin. ACNES often presents as severe unilateral pain in a predictable area of the anterior abdomen that harbors altered skin sensations, such as hypoesthesia, hyperesthesia, and changed cool perception [3]. Squeezing the skin and subcutaneous tissue between the thumb and index finger in this area (pinch test) is disproportionally painful. Located centrally in this area is a spot of maximal tenderness (tender point, TP) that is Carnett positive, i.e., increased pain when simultaneously tensing the rectus abdominis muscle and palpating the painful area [4]. Pain reduction after local injection of an anesthetic agent at the TP supports a diagnosis of ACNES.
A large population study (n = 1116 patients) found that the median diagnostic delay for ACNES was 18 months [6]. The long delay is likely because approximately half of painful ACNES patients also report a range of visceral symptoms such as nausea, bloating, or loss of appetite mimicking visceral entities [6]. This high proportion may contribute to many ACNES patients being wrongfully diagnosed with having a functional abdominal pain syndrome [7]. Such patients are evaluated not only by general practitioners, but also by internal medicine physicians and gastro-enterologists.
Visceral symptoms in ACNES may be an expression of so-called segmental phenomena. For instance, bloating, or the feeling of abdominal distension, may be caused by abnormal viscerosomatic reflexes and may contribute to actual girth distension [8]. ACNES may, therefore, reflect a compromised segmental relation between a viscus and the corresponding somatic nerve, resulting in a painful head zone. This zone is a somatic nerve dermatome with altered skin sensation and painful spots associated with a viscus at an advanced stage of disease [9]. For example, hyperesthesia of the T10–11 dermatome in the right lower abdominal area may reflect acute appendicitis [10].
The aim of the present study is to gain more insight into the visceral complaints among ACNES patients and the effect of treatment on these complaints.
Methods
Setting and design
This prospective observational study was conducted between July 2017 and December 2020 at the Center of Excellence for Chronic Abdominal Wall and Groin Pain. Clinicians at this institute have gained vast experience over the past 15 years in the treatment of chronic abdominal wall pain syndromes, including ACNES [11]. Patients referred for evaluation of chronic abdominal pain are first requested to complete a standard intake questionnaire that includes demographics, history and other specifics. Each patient suspected of having ACNES is then invited to our outpatient department for evaluation by a dedicated team of surgeons, physicians and physician assistants. For the purpose of this study, consecutive patients were recruited by one of the senior authors (RR or MS), but treated by the entire team of physicians. To avoid bias, the first author only performed study procedures after the patients had been treated. All patients had given informed consent prior to intake, and the study protocol was approved by the Medical Ethics Committee of our hospital (M17.115).
Patient assessment
Study criteria were the presence of previously reported diagnostic criteria for ACNES [12, 13]:
-
predictable site of abdominal tenderness with a small (< 2 cm diameter) area of maximal intensity (tender point, TP) located within the lateral boundaries of the rectus abdominis muscle
-
unilateral or bilateral TP
-
presence of somatosensory skin disturbances covering the TP, such as altered cool sensation, hypoesthesia, or hyperesthesia
-
intense pain while squeezing the abdominal wall skin covering the TP (pinch test)
-
increased tenderness after abdominal muscle tensing with (Carnett’s test)
Only ACNES patients who reported at least one visceral symptom related to the perceived abdominal pain during the intake consultation were eligible for entry to the study. Exclusion criteria were recently treated elsewhere for ACNES, recent intra-abdominal pathology, lidocaine allergy, pregnancy, and language barrier.
Management of ACNES
If the patient was diagnosed with ACNES, a freehand subfascial injection of 1% lidocaine (5–10 mL) was administered just beneath the anterior rectus sheath at the TP, as reported previously [14]. Three consecutive injection sessions were scheduled for the following 6 weeks. If the residual level of pain was acceptable, subsequent injections were canceled [15]. If pain reduction was insufficient after this regimen, pulsed radio frequency (PRF) or surgical removal of the nerve (anterior neurectomy) was proposed [16]. The various steps in this treatment strategy were determined in a shared decision environment with the patient.
Visceral Complaints ACNES Score
A Visceral Complaints ACNES Score (VICAS) questionnaire in Dutch language was developed by the senior authors based on their subjective, long-term experience with ACNES treatment. A total of 9 visceral symptoms related to the pain were scored. Each patient was asked whether a visceral symptom was present (yes, 1 point) or absent (no, 0 point), thus giving a minimum score of 1 (just one visceral symptom) and a maximum score of 9 points (all visceral symptoms present; Table 1). Belching was defined as the process of releasing accumulated air in the stomach by the mouth, thereby relieving distension or discomfort. Retching was the sound and/or movement of vomiting without actually vomiting. Abdominal bloating was the subjective feeling of an increased size of the abdomen. Urinary tract complaints could be due to a variety of symptoms and were not well predefined. The questionnaire was completed by participants before treatment, and again at least three months after the final treatment step.
Outcome measures
Baseline characteristics such as length, weight, numeric rating scale for pain (score of 0–10, where 0 = no pain and 10 = worst pain) were obtained from the completed questionnaires and electronic patient files. The main outcomes were the frequency and the number (VICAS) of various visceral symptoms prior to treatment in ACNES patients. Next, the relationship between the presence of visceral symptoms and the outcome from ACNES treatment was evaluated. Treatment outcome was based on pain reduction. A four-point patient satisfaction score for pain reduction was obtained from the options shown below. This was obtained by telephone by the first author after completion of the final treatment step, as reported previously [14]:
-
(1)
I am very satisfied (> 95% pain reduction)
-
(2)
I am satisfied, but I occasionally experience some pain (≥ 50% pain reduction)
-
(3)
I have improved, but experience some pain on a regular basis (< 50% pain reduction)
-
(4)
The treatment did not change my pain level, or made my pain worse
Treatment outcome was considered successful if the patient’s response was category 1 or 2, and unsuccessful if it was 3 or 4. If the patient did not respond after two telephone attempts, the questionnaire was sent by mail. If this questionnaire was not returned, the patient was considered as lost to follow-up.
Statistical methods
An arbitrary sample size of 100 completed questionnaires was targeted a priori. Anticipating a 10% drop-out rate, 110 patients were needed. Continuous data were presented as the mean and standard deviation (SD) if parametric, and median and range if non-parametric. Categorical variables were presented as a count and percentage. Continuous variables were analyzed using the t test for parametric variables, and the Mann–Whitney U test (unpaired) or Wilcoxon signed-rank test (paired) for non-parametric variables. Categorical variables were analyzed using the McNemar test, Pearson Chi-square test, or Fisher’s exact test as appropriate. Univariate logistic regression analysis was used to determine whether baseline VICAS or patient characteristics were predictive of the overall treatment outcome. Patient characteristics associated with treatment outcome (i.e., p < 0.1) were entered into a multivariate analysis together with VICAS. This was used to study the effect of baseline VICAS on treatment outcome, while accounting for possible confounders. A p value ≤ 0.05 was considered to represent statistical significance. Data analysis was performed using SPSS version 23 for Windows.
Results
A total of 111 patients from July 2017 to August 2018 fulfilled the study criteria. Eleven patients were excluded due to ineligibility, giving a final cohort of 100 patients for the analysis (Fig. 1). Of these, 13 patients were lost to follow-up, giving 87 patients in whom evolution of visceral symptoms could be determined. Baseline characteristics for the patients are presented in Table 2.
Visceral symptoms
The frequencies of visceral symptoms in ACNES patients are shown in Table 3. A median of three visceral symptoms (range 1–8) was reported. Apart from the obligatory abdominal pain, the other most frequent visceral complaints were bloating, nausea and altered defecation.
Visceral symptoms in relation to tender point location
The relation between TP location and type of visceral symptom was studied in patients with a unilateral ACNES (n = 75; Fig. 2). Figure 2 shows the distribution of the various symptoms. Half the patients (51%) had a TP in the right lower abdominal quadrant. No pattern of preferred symptoms was seen in any of the abdominal quadrants.
Relation of visceral symptoms and ACNES treatment outcome
The changes in visceral symptoms following treatment are shown in Table 4. Successful treatment significantly reduced 7 of 9 visceral symptoms, as reflected also by the fall in median VICAS from 3 before treatment to 1 afterwards (p < 0.001). Visceral symptoms did not change in patients who reported an unsuccessful outcome (p = 0.777). Before treatment, the median VICAS was 3 in the successfully treated group and 5 in the unsuccessful group (p = 0.005).
Figure 3 shows the proportion of patients who reported the disappearance of an earlier visceral symptom after successful or failed treatment. For example, of the patients who experienced nausea before treatment, this condition disappeared in 78% of successfully treated patients but in just 8% of those who were unsuccessfully treated.
Predictive factors for ACNES treatment outcome
A low baseline VICAS was significantly associated with the successful treatment of ACNES (OR 0.738, 95% CI 0.546–0.999). However, patient gender, age, baseline NRS and bilateral TP location were not predictive of treatment outcome and, therefore, multivariate analysis was not indicated.
Discussion
The aim of this study was to describe the spectrum of visceral symptoms experienced by patients diagnosed with ACNES. Although pain is a hallmark of ACNES, approximately 50% of patients also experience a range of visceral complaints such as bloating or nausea [6]. This correlation has not been described in detail in the previous literature on ACNES. The present results show that selected ACNES patients report a median of three visceral symptoms. Moreover, successful ACNES treatment reversed most of these symptoms. Our results indicate that treatment failure for ACNES is related to the number of visceral symptoms. To the best of our knowledge, this is the first study describing and evaluating the specific relation between abdominal wall pain and visceral symptoms.
The presence of visceral symptoms in patients suffering from ACNES is potentially misleading, since this suggests a visceral origin. This presentation often leads to delayed or incorrect diagnosis, futile investigations, and excessive medical costs. Abdominal bloating, nausea and altered defecation are the most frequently reported visceral symptoms in ACNES. However, these are often also experienced by patients with irritable bowel syndrome (IBS). For example, 3.6% of patients diagnosed with IBS were instead found to have ACNES [7]. ACNES should, therefore, be considered in the differential diagnosis of abdominal pain in patients with various visceral symptoms. A previously published, 18-item chronic abdominal wall pain scoring list clearly distinguished an abdominal wall-related pain entity from a more functional pain syndrome, including IBS [17]. In our experience, ACNES patients with such gastro-intestinal complaints are often evaluated initially by gastro-enterologists and internal medicine physicians. A significant doctor’s delay may occur if these specialists are not familiar with the diagnosis of ACNES [6].
The present study found that bloating was the most frequent visceral complaint in patients with ACNES, being reported in 78% of selected patients. Bloating, defined as the subjective sensation of abdominal distension, can affect from 10 to 30% of the general adult population and is often mentioned in patients with various gut disorders [18, 19]. Nevertheless, there is little available research on this topic. A review by Azpiroz and Malagelada provides an overview of the possible mechanisms of bloating. They hypothesized that bloating may be due to an abnormal viscerosomatic reflex involving abdominal distension and muscular wall dystonia [19]. A subsequent study showed this latter mechanism was responsible for a change in girth [8]. Viscerosomatic reflexes are also observed during other conditions, such as myocardial infarction causing pain radiating towards the arm, or in hepatobiliary disease that causes upper shoulder pain [20]. In 1907 already, Burns stated that “viscerosomatic reflexes would be impossible if viscero-sensory nerves did not enter the cord, or if they did not form either direct or indirect physiological relations with the somato-motor neuron” [21]. Moreover, the impulses should enter through the posterior roots of the spinal cord. Apart from viscerosomatic reflexes, somatovisceral reflexes also exist and have been hypothesized to explain the mechanism of action of sacral nerve stimulation in reducing fecal incontinence [22]. Bielefeldt et al. confirmed that multiple peripheral mechanisms (viscerosomatic, somatovisceral, and viscerovisceral convergence) lead to the development of hypersensitivity, thereby affecting neighboring organs or cutaneous referral sites [23]. Neuro-anatomy reveals that splanchnic nerves and somatic nerves are interconnected by the rami communicantes just before entering the spinal cord at the dorsal root (Fig. 4) [24]. This finding has led to the “convergence-projection theory”, which hypothesizes that dorsal horn neurons receive visceral input and convergent somatic input from the skin and/or muscle [25]. A recent in vitro thoracic spinal cord study showed that somatic and visceral C-fiber afferents converge mono-synaptically onto group lamina I neurons in the dorsal root [26]. These reflexes are also called segmental relations, reflecting the embryologic connection between various tissues including skin, muscles, bones and also the intestines that originate from the same segment. Therefore, based on the dorsal root reflex theory, the abdominal pain seen in ACNES may reflect such a disturbed segmental relationship [27]. Current daily medical practice with its emphasis on imaging and functional testing largely ignores the relevance of these phenomena.
We hypothesize that ACNES may result from a compromised segmental relation between a somatic (intercostal) nerve and the corresponding viscus, potentially resulting in a painful Head zone. In 1893, Sir Henry Head suggested that advanced visceral disease could lead to areas of altered skin sensation, with painful spots reflecting the (jeopardized) relation between a viscus and the corresponding somatic nerve dermatome [9]. Whereas the tender point in about half of ACNES patients is located in the right lower abdominal quadrant (T10–11), ACNES patients with a bariatric history are more prone to have a tender point in the left upper quadrant (T7–8) [28]. This latter type may be explained by a disturbed segmental relationship between the left 7–9th thoracic intercostal nerves and the splanchnic nerves innervating the stomach [29]. Furthermore, 40% of patients with acute appendicitis experienced altered skin sensations in the T10–11 right lower abdominal dermatome prior to appendectomy [10]. Interestingly, these changes were transient and disappeared postoperatively, suggesting that intercostal nerve pain may be associated with visceral disturbances and (temporary) loss or alteration of autonomic nerve system control.
A limitation of the present study is that the results are not applicable to all patients suffering from ACNES. Although a specific subgroup of ACNES patients was selected for this study, up to half of the general ACNES population may present with the same visceral symptoms [6]. Moreover, the size of the overall study cohort was relatively small, in particular the group with an unsuccessful response to treatment (n = 19). This study should, therefore, be regarded as descriptive and hypothesis generating. Another limitation involves the fact that VICAS is based on our own experience and requires further, independent validation. In addition, a possible relation between subjective treatment satisfaction and visceral symptoms was not studied. Since we only evaluated satisfaction in relation to pain reduction, patients may also have unintentionally considered a reduction (or not) in their visceral symptoms when reporting satisfaction for pain reduction. Future research should compare the characteristics of ACNES patients with and without visceral symptoms. To gain more insight into the origin of these symptoms in ACNES patients, it may be useful to compare the visceral symptoms of patients with ACNES to those of patients with other abdominal pathologies.
Conclusion
A selected group of patients reporting abdominal pain concomitant with ACNES may experience a range of associated visceral symptoms. These symptoms can confuse the practitioner and lead to a prolonged search for a visceral origin of the pain, while overlooking a possible link to the abdominal wall. Adequate treatment for ACNES may reduce the pain, as well as the accompanying visceral symptoms. Therefore, ACNES should be included in the differential diagnosis of patients with visceral symptoms and abdominal pain. Further research is required on the clinical role of the involved, but often forgotten, segmental relationships between visceral and somatic innervation.
Data availability
The authors will consider data and video sharing requests on a case-by-case basis. Requests should be sent to the corresponding author for further information.
References
Srinivasan R, Greenbaum DS (2002) Chronic abdominal wall pain: a frequently overlooked problem. Practical approach to diagnosis and management. Am J Gastroenterol 97:824–830
Applegate WV (2002) Abdominal cutaneous nerve entrapment syndrome (ACNES): a commonly overlooked cause of abdominal pain. Perm J 6(3):20–27
Scheltinga M, Roumen R (2018) Anterior cutaneous nerve entrapment syndrome (ACNES). Hernia 22(3):507–516. https://doi.org/10.1007/s10029-017-1710-z
Carnett JB (1926) Intercostal neuralgia as a cause of abdominal pain and tenderness. Surg Gynecol Obstet 42:625–632
Applegate WV, Buckwalter NR (1997) Microanatomy of the structures contributing to abdominal cutaneous nerve entrapment syndrome. J Am Board Fam Pract 10(5):329–332
Mol FMU, Maatman RC, De Joode LEGH, van Eerten P, Scheltinga MR, Roumen R (2019) Characteristics of 1116 consecutive patients diagnosed with anterior cutaneous nerve entrapment syndrome (ACNES). Ann Surg. https://doi.org/10.1097/SLA.0000000000003224
van Assen T, de Jager-Kievit JW, Scheltinga MR, Roumen RMH (2013) Chronic abdominal wall pain misdiagnosed as functional abdominal pain. J Am Board Fam Med 26(6):738–744. https://doi.org/10.3122/jabfm.2013.06.130115
Tremolaterra F, Villoria A, Azpiroz F, Serra J, Aguadé S, Malagelada JR (2006) Impaired viscerosomatic reflexes and abdominal-wall dystionia associated with bloating. Gasteroenterology 130(4):1062–1068. https://doi.org/10.1053/j.gastro.2005.12.036
Head H (1893) On disturbances of sensation with especial reference to the pain of visceral disease. Part I Brain 16(1–2):1–133. https://doi.org/10.1093/brain/16.1-2.1
Roumen RMH, Vening W, Wouda R, Scheltinga M (2017) Acute appendicitis, somatosensory disturbances (“Head Zones”), and the differential diagnosis of anterior cutaneous nerve entrapment syndrome (ACNES). J Gastrointest Surg 21(6):1055–1061. https://doi.org/10.1007/s11605-017-3417-y
Roumen RM, Scheltinga MR (2006) Abdominal intercostal neuralgia: a forgotten cause of abdominal pain. Ned Tijdschr Geneeskd 150:1909–1915
Boelens OB, van Assen T, Houterman S, Scheltinga MR, Roumen RM (2013) A double-blind, randomized, controlled trial on surgery for chronic abdominal pain due to anterior cutaneous nerve entrapment syndrome. Ann Surg 257(5):845–849. https://doi.org/10.1097/SLA.0b013e318285f930
Boelens OB, Scheltinga MR, Houterman S, Roumen RM (2013) Randomized clinical trial of trigger point infiltration with lidocaine to diagnose anterior cutaneous nerve entrapment syndrome. Br J Surg 100(2):217–221. https://doi.org/10.1002/bjs.8958
Boelens OB, Scheltinga MR, Houterman S, Roumen RM (2011) Management of anterior cutaneous nerve entrapment syndrome in a cohort of 139 patients. Ann Surg 254(6):1054–1058. https://doi.org/10.1097/SLA.0b013e31822d78b8
Mol FMU, Jansen CH, Boelens OB, Stronks DL, Eerten PV, Huygen FJPM, Scheltinga MR, Roumen RM (2018) Adding steroids to lidocaine in a therapeutic injection regimen for patients with abdominal pain due to anterior cutaneous nerve entrapment syndrome (ACNES): a single blinded randomized clinical trial. Scand J Pain 18:505–512. https://doi.org/10.1515/sjpain-2018-0011
Maatman RC, van Kuijk SMJ, Steegers MAH, Boelens OBA, Lim TC, Scheltinga MRM, Roumen RMH (2019) A randomized controlled trial to evaluate the effect of pulsed radiofrequency as a treatment for anterior cutaneous nerve entrapment syndrome in comparison to anterior neurectomy. Pain Pract 19:751–761. https://doi.org/10.1111/papr.12806
Van Assen T, Boelens OB, Kamphuis JT, Scheltinga MR, Roumen RM (2012) Construction and validation of a questionnaire distinguishing a chronic abdominal wall pain syndrome from irritable bowel syndrome. Frontline Gastroenterol 3(4):288–294. https://doi.org/10.1136/flgastro-2012-100207
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterol 130(5):1480–1491. https://doi.org/10.1053/j.gastro.2005.11.061
Azpiroz F, Malagelada JR (2005) Abdominal bloating. Gasteroenterol 129(3):1060–1078. https://doi.org/10.1053/j.gastro.2005.06.062
Bath M, Owens J (2001) Physiology, viscerosomatic reflexes. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559218/. Accessed June 2021
Burns L (2000) Viscero-somatic and somato-visceral spinal reflexes. J Am Osteopath Assoc 100(4):249–258
Gourcerol G, Vitton V, Leroi AM, Michot F, Abysique A, Bouvier M (2011) How sacral nerve stimulation works in patients with faecal incontinence. Colorectal Dis 13(8):203–211. https://doi.org/10.1111/j.1463-1318.2011.02623.x
Bielefeldt K, Lamb K, Gebhart GF (2006) Convergence of sensory pathways in the development of somatic and visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 291(4):G658–G665. https://doi.org/10.1152/ajpgi.00585.2005
Kansal A, Hughes J (2019) Visceral pain. Anaesth Intensive Care Med 20(10):550–554. https://doi.org/10.1016/j.mpaic.2019.07.014
Gebhart GF, Bielefeldt K (2016) Physiology of visceral pain. Compr Physiol 6(4):1609–1633. https://doi.org/10.1002/cphy.c150049
Luz LL, Fernandes EC, Sivado M, Kokai E, Szucs P, Safronov BV (2005) Monosynaptic convergence of somatic and visceral C-fiber afferents on projection and local circuit neurons in lamina I: a substrate for referred pain. Pain 156(10):2042–2051. https://doi.org/10.1097/j.pain.0000000000000267
Fang Y, Han S, Li X, Xie Y, Zhu B, Gao X, Ma C (2021) Cutaneous hypersensitivity as an indicator of visceral inflammation via C-nociceptor axon bifurcation. Neurosci Bull 37(1):45–54. https://doi.org/10.1007/s12264-020-00577-5
Jansen CMAH, Bonouvrie DS, Jacobs MLYE, Janssen N, Leclercq WKG, Scheltinga MRM, Roumen RMH (2020) Chronic abdominal pain after previous bariatric surgery: consider the abdominal wall. Obes Surg 30(8):2942–2948. https://doi.org/10.1007/s11695-020-04629-7
Ruiz-Tovar J, Oller I, Diez M, Zubiaga L, Arroyo A, Calpena R (2014) Percutaneous electrical neurostimulation of dermatome T6 for appetite reduction and weight loss in morbidly obese patients. Obes Surg 24(2):205–211. https://doi.org/10.1007/s11695-013-1091-z
Funding
No specific grant or funding was received for this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jacobs, M.L.Y.E., Janssen, L., Stassen, L.P.S. et al. Visceral symptoms in patients with anterior cutaneous nerve entrapment syndrome (ACNES): expression of viscerosomatic reflexes?. Hernia 28, 127–134 (2024). https://doi.org/10.1007/s10029-023-02827-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10029-023-02827-7